KHK-1

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameKHK-1

Drug Alias NameDicer-substrate small interfering RNAs (Dicerna)Dicer-substrate small interfering RNAs (Dicerna/Kyowa Hakko Kirin)DsiRNAs program (Dicerna/Kyowa Hakko Kirin)DsiRNAs (Dicerna)KHK-1

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA

Mechanisms of ActionV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog inhibitors

TargetsGTPase KRas

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesJapan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesDicerna Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesKyowa Kirin Co Ltd Dicerna Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A